Literature DB >> 1833877

Bovine coronavirus nonstructural protein ns2 is a phosphoprotein.

G J Cox1, M D Parker, L A Babiuk.   

Abstract

To investigate the nature of the bovine coronavirus (BCV) ns2 protein, the gene encoding this protein was cloned and was expressed as a beta-galactosidase fusion protein. Antiserum raised against this protein reacted specifically with BCV-infected fixed cells in indirect immunofluorescence microscopy and precipitated an in vitro synthesized product approximately 32-kDa in molecular weight and an equivalent protein from BCV-infected cells. The synthesis of ns2 was found to be similar to the structural proteins of BCV and pulse-chase experiments indicated that ns2 protein was stable and that it accumulated in BCV-infected cells. Synthesis of ns2 in the presence of [32P] orthophosphate revealed that it is a phosphoprotein. Phosphoamino acid analysis confirmed the phosphorylated nature of ns2 and identified serine and threonine as its phosphorylated amino acid residues. This is the first demonstration of a phosphorylated nonstructural protein in coronavirus-infected cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1833877      PMCID: PMC7131063          DOI: 10.1016/0042-6822(91)90810-x

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  23 in total

Review 1.  Coronavirus: organization, replication and expression of genome.

Authors:  M M Lai
Journal:  Annu Rev Microbiol       Date:  1990       Impact factor: 15.500

Review 2.  Coronaviruses: structure and genome expression.

Authors:  W Spaan; D Cavanagh; M C Horzinek
Journal:  J Gen Virol       Date:  1988-12       Impact factor: 3.891

3.  Cloning and in vitro expression of the gene for the E3 haemagglutinin glycoprotein of bovine coronavirus.

Authors:  M D Parker; G J Cox; D Deregt; D R Fitzpatrick; L A Babiuk
Journal:  J Gen Virol       Date:  1989-01       Impact factor: 3.891

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

6.  RNA-dependent RNA polymerase activity in murine coronavirus-infected cells.

Authors:  B W Mahy; S Siddell; H Wege; V ter Meulen
Journal:  J Gen Virol       Date:  1983-01       Impact factor: 3.891

7.  Identification and stability of a 30-kDa nonstructural protein encoded by mRNA 2 of mouse hepatitis virus in infected cells.

Authors:  P J Bredenbeek; A F Noten; M C Horzinek; W J Spaan
Journal:  Virology       Date:  1990-03       Impact factor: 3.616

8.  Primary structure of the S peplomer gene of bovine coronavirus and surface expression in insect cells.

Authors:  M D Parker; D Yoo; G J Cox; L A Babiuk
Journal:  J Gen Virol       Date:  1990-02       Impact factor: 3.891

9.  Cleavage-site preferences of Sindbis virus polyproteins containing the non-structural proteinase. Evidence for temporal regulation of polyprotein processing in vivo.

Authors:  R J de Groot; W R Hardy; Y Shirako; J H Strauss
Journal:  EMBO J       Date:  1990-08       Impact factor: 11.598

10.  DNA is linked to the rat liver DNA nicking-closing enzyme by a phosphodiester bond to tyrosine.

Authors:  J J Champoux
Journal:  J Biol Chem       Date:  1981-05-25       Impact factor: 5.157

View more
  9 in total

1.  Evolutionary history of the closely related group 2 coronaviruses: porcine hemagglutinating encephalomyelitis virus, bovine coronavirus, and human coronavirus OC43.

Authors:  Leen Vijgen; Els Keyaerts; Philippe Lemey; Piet Maes; Kristien Van Reeth; Hans Nauwynck; Maurice Pensaert; Marc Van Ranst
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

2.  Organ-specific attenuation of murine hepatitis virus strain A59 by replacement of catalytic residues in the putative viral cyclic phosphodiesterase ns2.

Authors:  Jessica K Roth-Cross; Helen Stokes; Guohui Chang; Ming Ming Chua; Volker Thiel; Susan R Weiss; Alexander E Gorbalenya; Stuart G Siddell
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

3.  Bovine coronaviruses associated with enteric and respiratory diseases in Canadian dairy cattle display different reactivities to anti-HE monoclonal antibodies and distinct amino acid changes in their HE, S and ns4.9 protein.

Authors:  A M Gélinas; M Boutin; A M Sasseville; S Dea
Journal:  Virus Res       Date:  2001-07       Impact factor: 3.303

Review 4.  The molecular biology of coronaviruses.

Authors:  M M Lai; D Cavanagh
Journal:  Adv Virus Res       Date:  1997       Impact factor: 9.937

5.  Isolation and sequence analysis of canine respiratory coronavirus.

Authors:  Kerstin Erles; Kai-Biu Shiu; Joe Brownlie
Journal:  Virus Res       Date:  2006-11-07       Impact factor: 3.303

6.  The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host.

Authors:  Cornelis A M de Haan; Paul S Masters; Xiaolan Shen; Susan Weiss; Peter J M Rottier
Journal:  Virology       Date:  2002-04-25       Impact factor: 3.616

Review 7.  Bovine Coronavirus and the Associated Diseases.

Authors:  Anastasia N Vlasova; Linda J Saif
Journal:  Front Vet Sci       Date:  2021-03-31

8.  The Genome Organization of the Nidovirales: Similarities and Differences between Arteri-, Toro-, and Coronaviruses.

Authors:  Antoine A F de Vries; Marian C Horzinek; Peter J M Rottier; Raoul J de Groot
Journal:  Semin Virol       Date:  2002-05-25

9.  Nucleotide and predicted amino acid sequences of all genes encoded by the 3' genomic portion (9.5 kb) of respiratory bovine coronaviruses and comparisons among respiratory and enteric coronaviruses.

Authors:  V N Chouljenko; K G Kousoulas; X Lin; J Storz
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.